Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Basler announces Vignetting Correction feature for correction of edge shadowing January 23, 2019 I/O Hubs with M8 Connectivity Simplify Integration, Reduce Costs January 11, 2019 Intrinsic ID Named ‘Ground-breaking Company in IoT Security’ March 18, 2019